Cargando…
Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy
BACKGROUND: Interleukin-5 (IL-5) is thought to play a pivotal role in the pathogenesis of asthma. High levels of circulating IL-5 have been documented in acute asthma. However, serum IL-5 levels in mild to moderate asthmatics and the influence of regular use of inhaled glucocorticoids, is not known....
Autores principales: | Joseph, Jose, Benedict, Sheela, Safa, Wassef, Joseph, Maries |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC394333/ https://www.ncbi.nlm.nih.gov/pubmed/15113433 http://dx.doi.org/10.1186/1471-2466-4-2 |
Ejemplares similares
-
The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
por: Dal Negro, Roberto Walter, et al.
Publicado: (2023) -
Effect of High Dose Inhaled Glucocorticoids on Quality of Life in Patients with Moderate to Severe Asthma
por: Choi, Jae-Sung, et al.
Publicado: (2005) -
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
por: Scaparrotta, Alessandra, et al.
Publicado: (2012) -
Inhaled glucocorticoid-induced metabolome changes in asthma
por: Daley-Yates, Peter, et al.
Publicado: (2022) -
A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene(®) MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma
por: Kerwin, Edward M., et al.
Publicado: (2020)